Accelrys Inc. (ACCL) Reports In-Line Q1 EPS, Posts FY11 Guidance
Tweet
Share
E-mailGet Alerts ACCL Hot Sheet
Price: $2.89 --0%
Financial Fact:
Amortization of completed technology: 2.85M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Amortization of completed technology: 2.85M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Accelrys Inc. (NASDAQ: ACCL) reported Q1 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $39.5 million versus the consensus estimate of $36.91 million.
Accelrys Inc. sees FY2011 EPS of $0.33-$0.35, versus the consensus of $0.34. Accelrys Inc. sees FY2011 revenue of $152-$156 million, versus the consensus of $152.07 million.
Accelrys Inc. sees FY2011 EPS of $0.33-$0.35, versus the consensus of $0.34. Accelrys Inc. sees FY2011 revenue of $152-$156 million, versus the consensus of $152.07 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
